Santé Active Edition – Synergy Pharm: Medical Writing Solutions
We have been serving the pharmaceutical industry, and more generally the scientific research community, for more than 30 years.
Every member of our team is an experienced medical writer with a PhD, and all are native English or French speakers with bilingual proficiency in French and English. We design and write medical marketing documents intended for the scientific community, healthcare professionals or the general public, as well as all the regulatory and clinical documentation required at the various stages of drug development, regardless of the therapeutic area. We also provide an editorial assistance service to support you in the publication of your research: from the correction of your article to its submission, and the drafting of responses to reviewers.
We work accurately and efficiently to meet your deadlines, while our compliance with international standards (CONSORT, ICH, etc.), systematic proofreading between medical writers, and attention to detail guarantee that your documents will be of the highest quality. Our adaptability and responsiveness lead us to develop privileged and ongoing relationships with our clients.
Each project is unique, and our team at Santé Active Edition-Synergy Pharm are on hand to adapt and respond to your requirements. Do not hesitate to contact us to discuss your needs, we are looking forward to assisting you with your projects!
Our latest news
European Patients’ Rights Day
April 18 is European Patients’ Rights Day (EPRD).
The European Charter of Patients’ Rights proclaims 14 rights that aim to guarantee “a high level of protection of human health” and to ensure the provision of high quality of health services in European countries, in particular during the Covid pandemic.
More specifically, this charter proclaims:
- The right to information (“access to all that scientific research and technological innovation makes available”),
- The right to consent for any procedure or treatment, but also for participation in clinical trials,
- The right to innovation (“right of access to innovative procedures, including diagnostic procedures”), which implies the right of access to treatments or medical devices assessed in clinical trials.
The European Clinical Trials Regulation (Regulation (EU) No 536/2014) also aims to guarantee the rights of patients, and all of the medical writers at Synergy Pharm/Santé Active Edition are committed to ensuring that information relating to compliance with ethical standards and good clinical practice is clearly stated in publications reporting the results of clinical trials.
Our regulatory medical writing team also provides other medical writing services for clinical projects, including the information notes and Informed Consent Forms (ICFs) that should be provided to patients before their inclusion in a clinical study, as well as other study-related documents: Clinical Study Protocols (CSPs), Investigator’s Brochures (IBs), Investigational Medicinal Product Dossiers (IMPDs) for Clinical Trial Authorizations (CTAs), Clinical Study Reports (CSRs), etc.
French “Week Against Cancer” 2022
On the occasion of the national “Week Against Cancer” campaign in France, it is important to highlight research efforts aimed at reducing the side effects associated with cancer treatments.
Indeed, while the range of treatments available – used alone or in combination – are effective against cancer, they can have many side effects, particularly on the skin. Xerosis is one of the most frequent side effects of cancer therapy and requires appropriate management to help maintain patient quality of life and prevent potential interruptions to cancer treatment.
A recent multicenter, real-world, phase IV study demonstrated the benefits of using an emollient containing a postbiotic in the management of 319 patients with xerosis associated with a range of cancer treatments (chemotherapy, targeted therapy, radiotherapy, hormonotherapy and immunotherapy).
A previous multicentre, real-world, phase IV study had already demonstrated the effectiveness of this emollient for the management of xerosis in 5,910 patients with a range of skin conditions (atopic dermatitis, senile xerosis, ichthyosis, psoriasis, prurigo nodularis of Hyde etc.) and underlying systemic conditions (diabetes mellitus, thyroid disease, renal insufficiency, etc.).
These two articles, published in Dermatology and Therapy and written by our medical writing team, can be found here:
Brain Awareness Week 2022
Next week (14th – 20th of March) is the 24th Brain Awareness Week (BAW), “a global campaign to foster public enthusiasm and support for brain science” (https://www.brainawareness.org/about/).
There are many events taking place across the world, and several activities are also being proposed to help you get involved in the campaign.
In France, the “Société des Neurosciences” is hosting an extensive program, with replays of a range of conferences also being made available.
Many of the topics covered are related to themes* that our medical writing team has addressed in the form of articles and/or sketchnotes for the general public in collaboration with the “Observatoire B2V des Mémoires” (B2V Memory Observatory): https://www.synpharm.com/en/sketchnote/
*Learning, Brain and Artificial Intelligence, Brain and New Technologies, Brain and Society, Brain and Sport, Sleep, The 5 senses, Emotions, Memory, The Sick Brain.